Labeling Change for Neprilozone. Labeling Change for Neprilozone — minor update. Impacts 6 markets and 3 variations.

Change Number
CHG-2021-0064
Type
Labeling Change
Status
In Progress
Owner
Nadia Petrova
Initiated
2022-12-20
Description

Labeling Change for Neprilozone — minor update

Impacted Markets (6)
US — United StatesAU — AustraliaES — SpainSG — SingaporeRU — RussiaPL — Poland
Impacted Modules
2.3.P
Linked Variations (3)
Variation #TypeApplicationStatusSubmittedApproved
TITCK-2024-0016-V316MajorTITCK-2024-0016Approved2022-11-182024-06-24
SFDA-2023-0017-V317Type IISFDA-2023-0017Draft2023-01-01—
SAHPRA-2022-0018-V318MinorSAHPRA-2022-0018Submitted——